117 patients are currently taking a treatment for Participate in clinical trial

Patients
Ocrelizumab 15
ALS Phase 2B Study CK-2017357 9
Dimethyl fumarate 9
Teriflunomide 8
ALS Phase 3 Study Dexpramipexole (KNS-760704) 7
Fingolimod Clinical Trial 7
ALS Phase 2 Study NP001 6
ALS Phase 3 Study Ceftriaxone 6
Rasagiline 4
Daclizumab 3
Fingolimod 3
Glatiramer acetate 3
Alemtuzumab 2
ALS Phase 2-3 Study Arimoclomol 2
Diaphragm Pacing Implant 2
Ibudilast 2
Lithium Carbonate 2
Parkinson's Phase 3 Study Creatine 2
Riluzole 2
Ursodiol 2
ALS Phase 2 Study KNS-760704 CL201 1
ALS Phase 3 Study TRO19622 1
Bevacizumab 1
Breathing exercises (such as respiratory therapy or using a meter) 1
Cabergoline 1
Clarithromycin 1
Creatine supplement 1
Dasatinib 1
Dermatology 1
Emtricitabine (FTC) 1
Estriol topical 1
Famciclovir 1
Fampridine (4-AP immediate release) 1
Interferon beta-1a IM Injection 1
Lenalidomide 1
Mexiletine 1
MRI (magnetic resonance imaging) 1
MS Phase 2 Study ACT-128800 1
MS Phase 3 Study Laquinimod BRAVO 1
Mycophenolate mofetil 1
NSCLC Phase I PBF-509 AdenONCO Study 1
Ofatumumab 1
Pre-fALS Observational Study 1369-2005 1
Probiotics/Prebiotics 1
Pyruvate-Creatine-Niacinimide 1
Rifampin 1
Vitamin B12 (cyanocobalamin) 1